Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 229.62 Billion JPY | -20.84% |
| 2023 | 290.08 Billion JPY | -13.11% |
| 2022 | 333.84 Billion JPY | 3.12% |
| 2021 | 323.73 Billion JPY | 61.95% |
| 2020 | 199.89 Billion JPY | 64.35% |
| 2019 | 121.62 Billion JPY | -23.59% |
| 2018 | 159.18 Billion JPY | -26.71% |
| 2017 | 217.19 Billion JPY | -18.14% |
| 2016 | 265.33 Billion JPY | 4.76% |
| 2015 | 253.28 Billion JPY | -26.97% |
| 2014 | 346.81 Billion JPY | -17.99% |
| 2013 | 422.88 Billion JPY | -20.26% |
| 2012 | 530.31 Billion JPY | 1.74% |
| 2011 | 521.25 Billion JPY | -4.8% |
| 2010 | 547.5 Billion JPY | 0.86% |
| 2009 | 542.85 Billion JPY | 91.98% |
| 2008 | 282.76 Billion JPY | -13.58% |
| 2007 | 327.2 Billion JPY | 20.4% |
| 2006 | 271.75 Billion JPY | 31.38% |
| 2005 | 206.84 Billion JPY | 49.13% |
| 2004 | 138.7 Billion JPY | 53.09% |
| 2003 | 90.59 Billion JPY | -16.55% |
| 2002 | 108.56 Billion JPY | -17.43% |
| 2001 | 131.48 Billion JPY | 0.0% |
| 2000 | - JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 248.46 Billion JPY | 0.98% |
| 2024 Q1 | 246.04 Billion JPY | -15.18% |
| 2024 FY | 229.62 Billion JPY | -20.84% |
| 2024 Q4 | 229.62 Billion JPY | 2.18% |
| 2024 Q3 | 224.71 Billion JPY | -9.56% |
| 2023 Q2 | 345.37 Billion JPY | 1.24% |
| 2023 FY | 290.08 Billion JPY | -13.11% |
| 2023 Q4 | 290.08 Billion JPY | -3.15% |
| 2023 Q1 | 341.15 Billion JPY | 2.19% |
| 2023 Q3 | 299.51 Billion JPY | -13.28% |
| 2022 FY | 333.84 Billion JPY | 3.12% |
| 2022 Q1 | 323.85 Billion JPY | 0.04% |
| 2022 Q3 | 341.51 Billion JPY | 8.72% |
| 2022 Q2 | 314.13 Billion JPY | -3.0% |
| 2022 Q4 | 333.84 Billion JPY | -2.25% |
| 2021 Q2 | 333.49 Billion JPY | 17.44% |
| 2021 Q1 | 283.97 Billion JPY | 42.06% |
| 2021 FY | 323.73 Billion JPY | 61.95% |
| 2021 Q4 | 323.73 Billion JPY | -2.83% |
| 2021 Q3 | 333.17 Billion JPY | -0.1% |
| 2020 Q3 | 210.92 Billion JPY | 74.61% |
| 2020 Q1 | 120.71 Billion JPY | -0.75% |
| 2020 Q4 | 199.89 Billion JPY | -5.23% |
| 2020 Q2 | 120.79 Billion JPY | 0.07% |
| 2020 FY | 199.89 Billion JPY | 64.35% |
| 2019 Q4 | 121.62 Billion JPY | -0.91% |
| 2019 FY | 121.62 Billion JPY | -23.59% |
| 2019 Q2 | 123.72 Billion JPY | -6.97% |
| 2019 Q1 | 132.98 Billion JPY | -16.46% |
| 2019 Q3 | 122.73 Billion JPY | -0.79% |
| 2018 Q2 | 172.94 Billion JPY | -20.36% |
| 2018 Q1 | 217.15 Billion JPY | -0.02% |
| 2018 FY | 159.18 Billion JPY | -26.71% |
| 2018 Q4 | 159.18 Billion JPY | -8.06% |
| 2018 Q3 | 173.13 Billion JPY | 0.11% |
| 2017 Q3 | 231.43 Billion JPY | 4.17% |
| 2017 Q2 | 222.16 Billion JPY | -14.01% |
| 2017 Q1 | 258.34 Billion JPY | -2.04% |
| 2017 FY | 217.19 Billion JPY | -18.14% |
| 2017 Q4 | 217.19 Billion JPY | -6.15% |
| 2016 Q1 | 254.33 Billion JPY | 0.42% |
| 2016 Q4 | 263.73 Billion JPY | 17.94% |
| 2016 Q2 | 224.05 Billion JPY | -11.91% |
| 2016 FY | 265.33 Billion JPY | 4.76% |
| 2016 Q3 | 223.6 Billion JPY | -0.2% |
| 2015 Q1 | 310.31 Billion JPY | -10.52% |
| 2015 FY | 253.28 Billion JPY | -26.97% |
| 2015 Q2 | 283.86 Billion JPY | -8.52% |
| 2015 Q3 | 285.4 Billion JPY | 0.54% |
| 2015 Q4 | 253.28 Billion JPY | -11.25% |
| 2014 Q4 | 346.81 Billion JPY | -2.87% |
| 2014 FY | 346.81 Billion JPY | -17.99% |
| 2014 Q3 | 357.04 Billion JPY | 0.34% |
| 2014 Q2 | 355.83 Billion JPY | -10.56% |
| 2014 Q1 | 397.84 Billion JPY | -5.92% |
| 2013 Q2 | 474.27 Billion JPY | -10.27% |
| 2013 Q1 | 528.56 Billion JPY | -0.33% |
| 2013 FY | 422.88 Billion JPY | -20.26% |
| 2013 Q4 | 422.88 Billion JPY | -3.05% |
| 2013 Q3 | 436.16 Billion JPY | -8.04% |
| 2012 Q2 | 542.08 Billion JPY | -6.46% |
| 2012 Q3 | 539.97 Billion JPY | -0.39% |
| 2012 Q4 | 530.31 Billion JPY | -1.79% |
| 2012 FY | 530.31 Billion JPY | 1.74% |
| 2012 Q1 | 579.49 Billion JPY | 11.17% |
| 2011 FY | 521.25 Billion JPY | -4.8% |
| 2011 Q2 | 535.67 Billion JPY | -1.97% |
| 2011 Q3 | 513.7 Billion JPY | -4.1% |
| 2011 Q4 | 521.25 Billion JPY | 1.47% |
| 2011 Q1 | 546.45 Billion JPY | -0.19% |
| 2010 Q1 | 540.59 Billion JPY | -0.42% |
| 2010 FY | 547.5 Billion JPY | 0.86% |
| 2010 Q3 | 552.7 Billion JPY | -1.5% |
| 2010 Q4 | 547.5 Billion JPY | -0.94% |
| 2010 Q2 | 561.12 Billion JPY | 3.8% |
| 2009 Q3 | 547.86 Billion JPY | 6.87% |
| 2009 FY | 542.85 Billion JPY | 91.98% |
| 2009 Q2 | 512.65 Billion JPY | 0.0% |
| 2009 Q4 | 542.85 Billion JPY | -0.91% |
| 2008 FY | 282.76 Billion JPY | -13.58% |
| 2007 FY | 327.2 Billion JPY | 20.4% |
| 2006 FY | 271.75 Billion JPY | 31.38% |
| 2005 FY | 206.84 Billion JPY | 49.13% |
| 2004 FY | 138.7 Billion JPY | 53.09% |
| 2003 FY | 90.59 Billion JPY | -16.55% |
| 2002 FY | 108.56 Billion JPY | -17.43% |
| 2001 FY | 131.48 Billion JPY | 0.0% |
| 2000 FY | - JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | -32458.533% |
| Ansell Limited | 706.6 Million USD | -32397.594% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -1024496.098% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -36740380.0% |
| ConvaTec Group Plc | 1.22 Billion USD | -18642.578% |
| ConvaTec Group Plc | 1.22 Billion USD | -18616.114% |
| Encision Inc. | 67.33 Thousand USD | -341018077.498% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -59980518.383% |
| LifePoint, Inc. | 151.73 Thousand USD | -151335790.44% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -4672834.473% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -37337786.179% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -127597239.453% |
| SmileDirectClub, Inc. | 849.37 Million USD | -26934.81% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -108842.073% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -473567100.808% |
| Vasamed, Inc. | 18.95 Thousand USD | -1211757155.937% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -1243383049.231% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -58811768.509% |